Cost and cost-effectiveness studies in heart failure research

Background Heart failure is a major and increasing cause of death and disability and accounts for significant resourse use. In the United States alone, the prevalence is 4.6 million, with an incidence rate of 550,000 new cases a year and approximately 957,000 hospitalizations a year. Methods and Res...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2002-04, Vol.143 (4), p.565-576
Main Authors: Weintraub, William S., Cole, Jason, Tooley, Joseph F.
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - economics
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Biological and medical sciences
Cardiology. Vascular system
Cost-Benefit Analysis
Costs and Cost Analysis
Decision Trees
Digoxin - economics
Digoxin - therapeutic use
Heart
Heart Failure - economics
Heart Failure - therapy
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Humans
Medical sciences
Outcome Assessment (Health Care)
Quality-Adjusted Life Years
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Heart failure is a major and increasing cause of death and disability and accounts for significant resourse use. In the United States alone, the prevalence is 4.6 million, with an incidence rate of 550,000 new cases a year and approximately 957,000 hospitalizations a year. Methods and Results Methods of evaluating cost and outcome and of comparing cost with outcome are reviewed. Economic and cost-effectiveness studies in heart failure research, especially those related to clinical trials, are reviewed in the therapeutic areas of digoxin, angiotension-converting enzyme inhibition, beta blockers, disease management, and transplantation. Conclusion In an era in which economic constraints on medical resourse use limit the ability to give all services to all patients, economic studies can help guide more rational decision making. Economic studies in heart failure can be expected to improve and so help society to make better, more informed choices. (Am Heart J 2002;143:565-76.)
ISSN:0002-8703
1097-6744
DOI:10.1067/mhj.2002.120965